Dr. Mishra (formerly with Genentech, Roche, NCI, NIH, DHHS, US Government) is the founding president and CEO of American Association for Precision Medicine (AAPM) and chair of ACT: AAPM Coronavirus Taskforce, leading research efforts focused on preventing and curing COVID-19, cancer, and other chronic diseases; not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives. He is a serial entrepreneur who founded his first company after graduating high school, and his second company while earning his Ph.D. Since then, he has accumulated a wealth of experience by building, investing, and advising numerous companies. He is an investor, co-founder/board member of a few corporations, focused on accelerating drug discovery/development, data analytics, robotics, mental health, and digital health.
Widely recognized as a Technology and Healthcare thought leader, Dr. Mishra has keynoted, chaired, and organized numerous successful international conferences. His research work has been recognized globally by over 40 prestigious awards and honors. Dr. Mishra also served as a Scientist and Principal Investigator at Genentech, Roche. Moreover, his passion for drug development and precision medicine has led to the identification of new drug targets, biomarkers, companion diagnostics, and several drugs/ combinations in the clinic. Due to his unique perspective and selfless service, he is a highly respected and sought-after mentor to many.
- Drug discovery & development
- Robotization & automation
- BigData analytics & AI driven R&D
- Genetics, cancer genomics, bioinformatics
- Stem cells, tumor microenvironment
- Oncology, Immunology, inflammation, fibrosis & anti-aging
- Translational & clinical research